Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glivin-M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Corvin Pharmaceuticals

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glivin-M 80mg/500mg Tablet

DiabetaComb 80mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This formulation helps regulate blood glucose in diabetic patients. DiabetaComb 80mg/500mg tablets should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-managed blood sugar, as abrupt cessation can elevate glucose levels, increasing risks of kidney complications, vision loss, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor; lifestyle modifications are essential for diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation and vomiting may also occur. Maintaining regular meals and carrying a readily available glucose source (e.g., sugary snacks or juice) is crucial for managing hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is a potential consequence for some users. This medication is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women should consult their doctor prior to use. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, may be recommended by your physician.

Primary Ingredients of Glivin-M 80mg/500mg Tablet

No text provided to rephrase.

Uses of Glivin-M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glivin-M 80mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glivin-M 80mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Take this medication with a meal.

Common Side effects of Glivin-M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glivin-M 80mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glivin-M 80mg/500mg tablet whole; do not crush, chew, or break it. Administer this medication with a meal.

How Glivin-M 80mg/500mg Tablet works:

Each Glivin-M 80mg/500mg tablet contains gliclazide and metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glivin-M 80mg/500mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glivin-M 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glivin-M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Caution is advised when prescribing Glivin-M 80mg/500mg tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not use Glivin-M 80mg/500mg tablets. Physician consultation is recommended. Kidney function should be regularly assessed during treatment with this medication.

LiverLiverCAUTION

Exercise caution when prescribing Glivin-M 80mg/500mg tablets to individuals with hepatic impairment; dosage modifications may be necessary. A physician's consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate therapy with a reduced Glivin-M 80mg/500mg tablet dosage; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Glivin-M 80mg/500mg Tablet :

Should you forget a Glivin-M 80mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glivin-M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glivin-M 80mg/500mg Tablet

Glivin-M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glivin-M 80mg/500mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glivin-M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glivin-M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glivin-M 80mg/500mg Tablets and seek immediate medical attention.
Prolonged Glivin-M 80mg/500mg Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glivin-M 80mg/500mg Tablets are contraindicated in patients allergic to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Combining Glivin-M 80mg/500mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glivin-M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glivin-M is not suitable for type 1 diabetes.
Glivin-M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glivin-M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glivin-M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glivin-M 80mg/500mg Tablets and seek immediate medical attention.
Prolonged Glivin-M 80mg/500mg Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait problems), urinary issues, cognitive changes, and balance difficulties. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Glivin-M 80mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also not be used by those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glivin-M 80mg/500mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar and raise the risk of lactic acidosis.
Glivin-M 80mg/500mg Table...
31
MRP 36
13% off